Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Yannuzzi LA, Wong DW, Sforzolini BS, Goldbaum M, Tang KC, Spaide RF et al. Polypoidal choroidal vasculopathy and neovascularized age related macular degeneration. Arch Ophthalmol 1999; 117: 1503–1510.
Chaikitmongkol V, Bressler NM . Dramatic resolution of choroidal neovascular abnormalities after single aflibercept injection following years of ranibizumab use. JAMA Ophthalmol 2013; 131: 260–262.
Kumar N, Marsiglia M, Mrejen S, Fung AT, Slakter J, Sorenson J et al. Visual and anatomical outcomes of intravitreal aflibercept in eyes with persistent subfoveal fluid despite previous treatments with ranibizumab in patients with neovascular age-related macular degeneration. Retina 2013; 33: 1605–1612.
Patel KH, Chow CC, Rathod R, Mieler WF, Lim JI, Ulanski 2nd, LJ et al. Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab. Eye (Lond) 2013; 27: 663–667.
Yonekawa Y, Andreoli C, Miller JB, Loewenstein JI, Sobrin L, Eliott D et al. Conversion to aflibercept for chronic refractory or recurrent neovascular age-related macular degeneration. Am J Ophthalmol. 2013; 156: 29–35.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Cheung, C., Mohla, A. & Wong, T. Resolution of persistent pigment epithelial detachment secondary to polypoidal choroidal vasculopathy in response to Aflibercept. Eye 28, 1148–1149 (2014). https://doi.org/10.1038/eye.2014.105
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2014.105
